DekaBank Deutsche Girozentrale’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-4,073
| Closed | -$239K | – | 1416 |
|
2022
Q2 | $239K | Hold |
4,073
| – | – | ﹤0.01% | 1157 |
|
2022
Q1 | $340K | Buy |
4,073
+373
| +10% | +$31.1K | ﹤0.01% | 1128 |
|
2021
Q4 | $786K | Buy |
3,700
+100
| +3% | +$21.2K | ﹤0.01% | 993 |
|
2021
Q3 | $975K | Hold |
3,600
| – | – | ﹤0.01% | 906 |
|
2021
Q2 | $933K | Hold |
3,600
| – | – | ﹤0.01% | 926 |
|
2021
Q1 | $1.05M | Hold |
3,600
| – | – | ﹤0.01% | 891 |
|
2020
Q4 | $985K | Sell |
3,600
-180
| -5% | -$49.3K | ﹤0.01% | 872 |
|
2020
Q3 | $941K | Buy |
+3,780
| New | +$941K | ﹤0.01% | 770 |
|
2019
Q4 | – | Sell |
-5,867
| Closed | -$1.59M | – | 1189 |
|
2019
Q3 | $1.59M | Sell |
5,867
-4,954
| -46% | -$1.34M | 0.01% | 579 |
|
2019
Q2 | $5.66M | Buy |
10,821
+4,425
| +69% | +$2.31M | 0.03% | 401 |
|
2019
Q1 | $6.39M | Buy |
6,396
+656
| +11% | +$655K | 0.04% | 381 |
|
2018
Q4 | $2.88M | Sell |
5,740
-656
| -10% | -$330K | 0.02% | 472 |
|
2018
Q3 | $6.39M | Sell |
6,396
-198
| -3% | -$198K | 0.04% | 385 |
|
2018
Q2 | $4.8M | Buy |
6,594
+2,407
| +57% | +$1.75M | 0.03% | 406 |
|
2018
Q1 | $6.6M | Buy |
4,187
+560
| +15% | +$882K | 0.05% | 349 |
|
2017
Q4 | $1.06M | Hold |
3,627
| – | – | 0.01% | 679 |
|
2017
Q3 | $1.06M | Hold |
3,627
| – | – | 0.01% | 688 |
|
2017
Q2 | $1.05M | Hold |
3,627
| – | – | 0.01% | 680 |
|
2017
Q1 | $1.27M | Buy |
3,627
+2,227
| +159% | +$777K | 0.01% | 572 |
|
2016
Q4 | $256K | Buy |
1,400
+107
| +8% | +$19.6K | ﹤0.01% | 792 |
|
2016
Q3 | $329K | Hold |
1,293
| – | – | ﹤0.01% | 749 |
|
2016
Q2 | $271K | Sell |
1,293
-2,534
| -66% | -$531K | ﹤0.01% | 805 |
|
2016
Q1 | $779K | Sell |
3,827
-660
| -15% | -$134K | 0.01% | 588 |
|
2015
Q4 | $1.16M | Buy |
4,487
+74
| +2% | +$19K | 0.01% | 547 |
|
2015
Q3 | $726K | Buy |
4,413
+153
| +4% | +$25.2K | 0.01% | 606 |
|
2015
Q2 | $799K | Buy |
4,260
+153
| +4% | +$28.7K | 0.01% | 607 |
|
2015
Q1 | $678K | Sell |
4,107
-440
| -10% | -$72.6K | 0.01% | 645 |
|
2014
Q4 | $1.05M | Sell |
4,547
-420
| -8% | -$96.8K | 0.01% | 554 |
|
2014
Q3 | $899K | Buy |
4,967
+127
| +3% | +$23K | 0.01% | 533 |
|
2014
Q2 | $931K | Buy |
4,840
+167
| +4% | +$32.1K | 0.01% | 509 |
|
2014
Q1 | $850K | Buy |
4,673
+273
| +6% | +$49.7K | 0.01% | 498 |
|
2013
Q4 | $764K | Buy |
4,400
+100
| +2% | +$17.4K | 0.01% | 482 |
|
2013
Q3 | $674K | Buy |
+4,300
| New | +$674K | 0.01% | 507 |
|